Association between hepatitis B virus infection and HLA-DR type in Korea
Open Access
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 31 (6) , 1371-1373
- https://doi.org/10.1053/jhep.2000.7988
Abstract
Although the mechanism of susceptibility to chronic persistent hepatitis B virus (HBV) infection is not well clarified, immunogenetic factors of the host may have a role. Recently, a strong association between HLA-DR13 and the self-limited course of HBV infection has been reported. To determine whether the elimination of HBV is related to a particular HLA allele, we studied the HBV markers and HLA-DR phenotypes of 1,272 Koreans who had visited Yonsei University Medical Center for renal transplantation. They included 330 renal transplant donors. Subjects were categorized into 3 different groups: the “Unexposed Group” (UE; n = 946) with negative HBV markers, the “Chronic Carrier Group” (CC; n = 83), who were hepatitis B surface antigen (HBsAg)-positive, and the “Spontaneously Cleared Group” (SC; n = 243), who were HBsAg-negative with antibodies to HBsAg (anti-HBs) and hepatitis B core antigen (anti-HBc). HLA-DR4 was the most common type in all groups. HLA-DR6 was significantly more frequent in 69 of 243 subjects with SC (28.4%) than in 8 of 83 subjects with CC (9.6%) (P < .001; relative risk [RR] = 3.72). HLA-DR9 was significantly more frequent in CC than in SC (P < .001; RR = 0.33). HLA-DR13 showed a stronger association with the clearance of HBV than the other HLA-DR6 subgroup. The distribution of HLA-DR phenotypes was similar regardless of renal disease. Our data indicate that HLA-DR6, especially HLA-DR13, is one of the host factors, which influences the immune response to HBV, and may be associated with self-elimination of HBV in Koreans.Keywords
This publication has 12 references indexed in Scilit:
- A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis BClinical and Experimental Immunology, 1998
- Host genetic factors influencing the outcome of hepatitisJournal of Viral Hepatitis, 1997
- HLA-DRB1*1301 AND *1302 protect against chronic hepatitis BJournal of Hepatology, 1997
- Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the GambiaNew England Journal of Medicine, 1995
- HLA and hepatitis B infectionThe Lancet, 1994
- The immune response to hepatitis B vaccine in humans: inheritance patterns in families.The Journal of Experimental Medicine, 1992
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccinationTissue Antigens, 1989
- HLA antigens in patients with various courses after hepatitis B virus infectionHepatology, 1987
- HEPATITIS B IMMUNE GLOBULIN (HBIG) EFFICACY IN THE INTERRUPTION OF PERINATAL TRANSMISSION OF HEPATITIS B VIRUS CARRIER STATEThe Lancet, 1981